We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Evidence-Based Dermatology: Consensus Conference |

Guidelines for Designing and Reporting Clinical Trials in Vitiligo

Urb à Gonz ález, MD, PhD; Maxine Whitton, BA (Hons), Hon MSc; Viktoria Eleftheriadou, MD; Mariona Pinart, PhD; Jonathan Batchelor, BMedSci, BM, BS, MRCP; Jo Leonardi-Bee, BSc(H), MSc, PGCHE, PhD
Arch Dermatol. 2011;147(12):1428-1436. doi:10.1001/archdermatol.2011.235.
Text Size: A A A
Published online


Objective To create guidelines for randomized controlled trials (RCTs) investigating interventions used in the management of vitiligo.

Participants Guideline developers included authors (clinicians, patient representatives, and a statistician) of the Cochrane systematic review “Interventions for Vitiligo ” plus the coordinator of the vitiligo priority-setting partnership at the Centre of Evidence-Based Dermatology at the University of Nottingham.

Evidence The guidelines are based on the assessment of the quality of design and reporting of RCTs evaluating interventions for vitiligo included in the 2010 update of the Cochrane systematic review “Interventions for Vitiligo. ”

Consensus Process We reviewed and commented on the sources of bias in existing RCTs on interventions for vitiligo (selection bias, blinding assessment, attrition bias, characteristics of participants, interventions, and outcomes) based on the findings of the Cochrane review, and we used open discussion on guideline drafts focusing on the study question (participants, interventions, and outcomes), study design (research methods), and reporting.

Conclusions Much opportunity exists for improving the design and reporting of vitiligo clinical trials. The proposed guidelines will help overcome methodologic challenges faced when conducting RCTs to answer treatment questions.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

14 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
[Treatment of vitiligo]. Hautarzt 2016;67(3):249-64.
Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report. J Oncol Pharm Pract Published online Sep 8, 2016;